Animal Blood Plasma Products & Derivatives

Animal Blood Plasma Products & Derivatives Market by Derivatives Type (Fetal Bovine Serum, Fibrinogen, Immunoglobulin), Animal Type (Bovine, Ovine) - Global Forecast 2024-2030

360iResearch Analyst
Want to know more about the animal blood plasma products & derivatives market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[184 Pages Report] The Animal Blood Plasma Products & Derivatives Market size was estimated at USD 752.59 million in 2023 and expected to reach USD 795.11 million in 2024, at a CAGR 5.76% to reach USD 1,114.33 million by 2030.

Animal Blood Plasma Products & Derivatives Market
To learn more about this report, request a free PDF copy
Animal blood plasma products and derivatives refer to components obtained from animal blood, primarily used for various therapeutic, nutraceutical, and pharmaceutical applications. Plasma derivatives include a range of bioactive components such as albumin, immunoglobulins, fibrinogen, and clotting factors, which play critical roles in physiological processes and are vital in the development of treatments for health conditions in both animals and humans. Several factors drive the demand for animal blood plasma components and derivatives. There is a growing need for animal-derived pharmaceuticals and the continual development of new biopharmaceuticals. Advances in bioscience and biotechnology also contribute to the utilization of these products. Moreover, the increasing prevalence of life-threatening diseases requiring plasma-derived proteins and the growing pet ownership with rising animal healthcare expenditure are pivotal drivers for expansion. The major challenges faced by animal blood plasma products and derivatives components include ethical concerns related to animal welfare, stringent regulations and compliances in plasma collection and processing, and the risks of transmission of zoonotic diseases. Additionally, the high cost associated with plasma fractionation and the availability of synthetic alternatives pose considerable challenges to market growth. Opportunities for animal blood plasma products and derivatives exist in the form of increasing investments in research and development for novel plasma-derived therapies. There is potential for expansion in emerging economies with improvement in their veterinary healthcare systems. The growing demand for high-quality feed additives for livestock performance is also a factor that may contribute to development. Furthermore, the enhancement of plasma collection and processing technologies promises to improve yield and reduce costs, thereby generating more opportunities.
Market Dynamics

The market dynamics represent an ever-changing landscape of the Animal Blood Plasma Products & Derivatives Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Growing utilization of animal blood plasma in veterinary care industry
    • Rising demand for animal meat and protein among human population
  • Market Restraints
    • Stringent regulations for safety and quality standards for animal blood plasma products
  • Market Opportunities
    • Ongoing innovations in biotechnology and processing techniques to improve the quality of animal blood plasma products
    • Increasing consumption of nutraceuticals and functional foods
  • Market Challenges
    • Availability of synthetic alternatives to animal blood plasma products
Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Animal Blood Plasma Products & Derivatives Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Animal Blood Plasma Products & Derivatives Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Animal Blood Plasma Products & Derivatives Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Animal Blood Plasma Products & Derivatives Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Animal Blood Plasma Products & Derivatives Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Animal Blood Plasma Products & Derivatives Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Animal Blood Plasma Products & Derivatives Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Animal Blood Plasma Products & Derivatives Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Animal Blood Plasma Products & Derivatives Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Animal Blood Plasma Products & Derivatives Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Animal Blood Plasma Products & Derivatives Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Animal Blood Plasma Products & Derivatives Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Animal Blood Plasma Products & Derivatives Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Animal Blood Plasma Products & Derivatives Market, highlighting leading vendors and their innovative profiles. These include ACROBiosystems Inc., Alfa Laval Corporate AB, ANZCO Foods Limited, Auckland BioSciences Ltd., BioChemed Services, Biowest Company, Canvax Reagents S.L., Ebrator Biochemicals Inc., Kraeber & Co. GmbH, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., Meiji Holdings Co., Ltd., Merck KGaA, Moregate Biotech, Pel-Freez, LLC, Rockland Immunochemicals, Inc., Scripps Laboratories, Inc., and TCS Biosciences Ltd..

Animal Blood Plasma Products & Derivatives Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Animal Blood Plasma Products & Derivatives Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Derivatives Type
    • Fetal Bovine Serum
    • Fibrinogen
    • Immunoglobulin
    • Serum Albumin
  • Animal Type
    • Bovine
    • Ovine

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Animal Blood Plasma Products & Derivatives Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Animal Blood Plasma Products & Derivatives Market, by Derivatives Type
  7. Animal Blood Plasma Products & Derivatives Market, by Animal Type
  8. Americas Animal Blood Plasma Products & Derivatives Market
  9. Asia-Pacific Animal Blood Plasma Products & Derivatives Market
  10. Europe, Middle East & Africa Animal Blood Plasma Products & Derivatives Market
  11. Competitive Landscape
  12. Competitive Portfolio
  13. List of Figures [Total: 20]
  14. List of Tables [Total: 196]
  15. List of Companies Mentioned [Total: 18]
Advancements in Biotechnology and Processing Techniques Used in Animal Blood Plasma Products and Derivatives
October 2, 2023
Advancements in Biotechnology and Processing Techniques Used in Animal Blood Plasma Products and Derivatives
When it comes to global demand and supply, the animal blood plasma products industry is growing at a steady pace. These products are precious to various industries, including cosmetics, pharmaceuticals, agriculture, and nutritional supplement companies. And, as technology and processing techniques continue to advance, the quality of animal blood plasma products and derivatives is also improving. This blog post discusses how these innovations significantly affect animal blood plasma products.

Better Handling and Processing Techniques:

The process of animal plasma collection has always been critical to the quality of animal blood plasma products and derivatives. In recent years, there have been ongoing improvements in the handling and processing techniques used in collecting plasma samples. The advancements in collection methods lead to higher-quality samples producing high-quality products. The plasma is collected from blood, typically from pigs, which gets screened for viruses and diseases before production. An improved testing and screening process helps in removing any impurities and viruses that may be present in the plasma.

Advanced Biotechnology Techniques:

Biotechnology, namely recombinant DNA technology and genetic engineering, has revolutionized animal blood plasma products and derivatives. New techniques are being developed to generate high yields of plasma proteins, which can facilitate the production of these products on a faster scale and more cost-effectively. Biotechnology also enables the development of specific proteins that can perform more specific functions than traditional animal blood plasma proteins.

Improving the Quality of Animal Blood:

Animal blood plasma products and derivatives are vital in the agricultural industry as they help grow healthy farm animals, such as pigs, cows, and chickens. Using animal blood plasma-based diets for animal feed helps improve growth, digestive function, nutrient utilization, and immune function. Scientific studies conducted globally have shown that diets formulated with animal blood plasma proteins reduce the risk of disease outbreaks in livestock, improve weaning weights, improve feed intake, and promote the development of gut health. Technological advancements in the animal blood plasma products industry have led to better quality blood collections, enabling more effective diets.

Biotechnology and processing techniques improve the quality of animal blood plasma samples, increasing the efficiency of collecting plasma samples for production. With the ongoing technological developments in animal blood plasma products, we can expect new and exciting uses of these products in the future.

Frequently Asked Questions
  1. How big is the Animal Blood Plasma Products & Derivatives Market?
    Ans. The Global Animal Blood Plasma Products & Derivatives Market size was estimated at USD 752.59 million in 2023 and expected to reach USD 795.11 million in 2024.
  2. What is the Animal Blood Plasma Products & Derivatives Market growth?
    Ans. The Global Animal Blood Plasma Products & Derivatives Market to grow USD 1,114.33 million by 2030, at a CAGR of 5.76%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.